Merck Intangible Assets from 2010 to 2026
| MRK Stock | USD 121.93 2.18 1.82% |
Intangible Assets | First Reported 1985-12-31 | Previous Quarter 15.2 B | Current Value 15.3 B | Quarterly Volatility 11.1 B |
Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 B, Interest Expense of 1.5 B or Total Revenue of 32.5 B, as well as many indicators such as Price To Sales Ratio of 4.53, Dividend Yield of 0.0238 or PTB Ratio of 6.86. Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
Merck | Intangible Assets | Build AI portfolio with Merck Stock |
Historical Intangible Assets data for Merck serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Merck Company represents a compelling investment opportunity.
Latest Merck's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Merck Company over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Merck's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merck's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Merck Intangible Assets Regression Statistics
| Arithmetic Mean | 18,471,810,882 | |
| Geometric Mean | 13,853,611,726 | |
| Coefficient Of Variation | 40.15 | |
| Mean Deviation | 5,226,707,405 | |
| Median | 18,011,000,000 | |
| Standard Deviation | 7,415,966,257 | |
| Sample Variance | 54996555.5T | |
| Range | 34.2B | |
| R-Value | (0.17) | |
| Mean Square Error | 56875466.7T | |
| R-Squared | 0.03 | |
| Significance | 0.50 | |
| Slope | (256,354,951) | |
| Total Sum of Squares | 879944888.3T |
Merck Intangible Assets History
About Merck Financial Statements
Merck investors utilize fundamental indicators, such as Intangible Assets, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 18.8 B | 14.5 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Merck Correlation against competitors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. Expected growth trajectory for Merck significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Merck assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.19) | Dividend Share 3.24 | Earnings Share 7.36 | Revenue Per Share | Quarterly Revenue Growth 0.05 |
Understanding Merck Company requires distinguishing between market price and book value, where the latter reflects Merck's accounting equity. The concept of intrinsic value - what Merck's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Merck's price substantially above or below its fundamental value.
Understanding that Merck's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merck represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Merck's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.